Relative adrenal insufficiency in mice deficient in 5α-reductase 1

Journal of Endocrinology

Volumn 222, Issue 2, 2014, Pages 257-266

  Livingstone, Dawn E W ^a   Di Rollo, Emma M ^a   Yang, Chenjing ^a   Codrington, Lucy E ^a   Mathews, John A ^a   Kara, Madina ^a   Hughes, Katherine A ^a   Kenyon, Christopher J ^a   Walker, Brian R ^a   Andrew, Ruth ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

5 reductases; Adrenal insufficiency; Glucocorticoids; HPA axis

Indexed keywords

ARGIPRESSIN; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; NR3C 1 PROTEIN; STEROID 5ALPHA REDUCTASE 1; UNCLASSIFIED DRUG;

ADRENAL GLAND WEIGHT; ADRENAL INSUFFICIENCY; ADRENALECTOMY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID METABOLISM; CORTICOSTERONE BLOOD LEVEL; GENOTYPE; GLUCOCORTICOID CLEARANCE; HYPOPHYSIS; HYPOTHALAMUS; IMMOBILIZATION STRESS; MALE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL;

5Α-REDUCTASES; ADRENAL INSUFFICIENCY; GLUCOCORTICOIDS; HPA AXIS;

3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE; 5-ALPHA REDUCTASE INHIBITORS; ADRENAL INSUFFICIENCY; ADRENOCORTICOTROPIC HORMONE; ANIMALS; CORTICOSTERONE; DEXAMETHASONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; PITUITARY-ADRENAL SYSTEM; STRESS, PSYCHOLOGICAL;

EID: 84905675786     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-13-0563     Document Type: Article

References (48)

1. Andrew R, Phillips DIW & Walker BR 1998 Obesity and gender influence cortisol secretion and metabolism in man. Journal of Clinical Endocrinology and Metabolism 83 1806-1809.
2. Annane D, Sebille V, Charpentier C, Bollaert P-E, Francois B, Korach J-M, Capellier G, Chen Y, Azoulay E, Troche G et al. 2002 Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. Journal of the American Medical Association 288 862-871.
3. Bao AM, Fischer DF, Wu YH, Balesar R, Unmehopa UA, Zhou JN & Swaab DF 2006 A direct androgenic involvement in the expression of human corticotropin-releasing hormone. Molecular Psychiatry 11 567-576.
4. Boonen E, Vervenne H, Meersseman P, Andrew R, Mortier L, Declercq PE, Vanwijngaeden Y-M, Spriet I, Wouters PJ, Vader Perre S et al. 2013 Reduced cortisol metabolism during critical illness. New England Journal of Medicine 368 1477-1488.
5. Burke ZD, Ho MY, Morgan H, Smith M, Murphy D & Carter D 1997 Repression of vasopressin gene expression by glucocorticoids in transgenic mice: evidence of a directmechanism mediated by proximal 50 flanking sequence. Neuroscience 78 1177-1185.
6. Carter RN, Paterson JM, Tworowska U, Stenvers DJ, Mullins JJ, Seckl JR & Holmes MC 2009 Hypothalamic-pituitary-adrenal axis abnormalities in response to deletion of 11b-HSD1 is strain-dependent. Journal of Neuroscience 21 879-887.
7. Cooper MS & Stewart PM 2009 11b-hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation. Journal of Clinical Endocrinology and Metabolism 94 4645-4654.
8. Draper N, Walker EA, Bujalska IJ, Tomlinson JW, Chalder SM, Arlt W, Lavery GG, Bedendo O, Ray DW, Laing I et al. 2003 Mutations in the genes encoding 11b-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nature Genetics 34 434-439.
9. Evans HC & Goa KL 2003 Dutasteride. Drugs & Aging 20 905-916.
10. Fassnacht M, Schlenz N, Schneider SB, Wudy SA, Allolio B & Arlt W 2003 Beyond adrenal and ovarian androgen generation: increased peripheral 5α-reductase activity in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 88 2760-2766.
11. Fernandez J, Escorell A, Zabalza M, Felipe V, Navasa M, Mas A, Lacy AM, Gines P & Arroyo V 2006 Adrenal insufficiency in patients with cirrhosis and septic shock. Hepatology 44 1288-1295.
12. Frey FJ 2006 Impaired 11b-hydroxysteroid dehydrogenase contributes to renal sodium avidity in cirrhosis: hypothesis or fact? Hepatology 44 795-801.
13. Fruzzetti F, de Lorenzo D, Parrini D & Ricci C 1994 Effects of finasteride, a 5α-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women. Journal of Clinical Endocrinology and Metabolism 79 831-835.
14. Han F, Ozawz H, Matsude K-I, Lu H, de Kloet ER & KawataM2007 Changes in the expression of corticotrophin-releasing hormone, mineralocorticoid receptor and glucocorticoid receptor mRNAs in the hypothalamic paraventricular nucleus induced by fornix transection and adrenalectomy. Journal of Neuroendocrinology 19 229-238.
15. Harris HJ, Kotelevtsev Y, Mullins JJ, Seckl JR & Holmes MC 2001 Intracellular regeneration of glucocorticoids by 11b-hydroxysteroid dehydrogenase (11b-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11b-HSD-1-deficient mice. Endocrinology 142 114-120.
16. Harry R, Auzinger G & Wendon J 2002 The clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology 36 395-402.
17. Herman JP & Spencer R 1998 Regulation of hippocampal glucocorticoid receptor gene transcription and protein expression in vivo. Journal of Neuroscience 18 7462-7473.
18. Holmes MC, French KL & Seckl JR 1995 Modulation of serotonin and corticosteroid receptor gene expression in the rat hippocampus with circadian rhythm and stress. Molecular Brain Research 28 186-192.
19. Imperato-McGinley J, Guerrero L, Gautier T & Peterson RE 1974 Steroid 5α-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 186 1213-1215.
20. Ing NH 2005 Steroid hormones regulate gene expression posttranscriptionally by altering the stabilities of messenger RNAs. Biology of Reproduction 72 1290-1296.
21. Jamieson A, Wallace AM, Walker BR, Andrew R, Fraser R, White PC & Connell JMC 1999 Apparent cortisone reductase deficiency: a functional defect in 11b-hydroxysteroid dehydrogenase type 1. Journal of Clinical Endocrinology and Metabolism 84 3570-3574.
22. Kotelevtsev YV,HolmesMC, BurchellA,HoustonPM, SchollD, Jamieson PM, Best R, Brown RW, Edwards CRW, Seckl JR et al. 1997 11b-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid inducible responses and resisthyperglycaemia onobesity and stress.PNAS 94 14924-14929.
23. Kotelevtsev YV, Brown RW, Fleming S, Edwards CRW, Seckl JR & Mullins JJ 1999 Hypertension in mice caused by inactivation of 11b-hydroxysteroid dehydrogenase type 2. Journal of Clinical Investigation 103 683-689.
24. Lavery GG, Walker EA, Draper N, Jeyasuria P, Marcos J, Shakleton CHL, Parker KL, White PC & Stewart PM 2006 Hexose-6-phosphate dehydrogenase knock-out mice lack 11b-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. Journal of Biological Chemistry 10 6546-6551.
25. Lephart ED 1999 Brain 5α-reductase: cellular, enzymatic, and molecular perspectives and implications for biological function. Molecular and Cellular Neuroscience 4 473-484.
26. Lephart ED 1993 Pituitary and brain 5α-reductase messenger RNA levels in control, castrated and dihydrotestosterone treated rats. Molecular and Cellular Neurosciences 4 526-531.
27. Lewis JG, George PM & Elder PA 1997 Plasma androsterone/epiandrosterone sulfates as markers of 5α-reductase activity: effect offinasteride innormal men. Steroids 62 632-635.
28. Livingstone DEW, Grassick S, Currie GL, Walker BR & Andrew R 2009 Dysregulation of glucocorticoid metabolism in murine obesity: comparable effects of leptin resistance and deficiency. Journal of Endocrinology 201 211-218.
29. Lund TD, Hinds LR & Handa RJ 2006 The androgen 5α-dihydrotestosterone and its metabolite 5α-androstan-3b, 17b-diol inhibit the hypothalamo- pituitary-adrenal response to stress by acting through estrogen receptor b-expressing neurons in the hypothalamus. Journal of Neuroscience 26 1448-1456.
30. Mahendroo MS, Cala KM & Russell DW 1996 5α-Reduced androgens play a key role in murine parturition. Molecular Endocrinology 10 380-392.
31. Mahendroo MS, Cala KM, Landrum CP & Russell DW 1997 Fetal death in mice lacking 5α-reductase type 1 caused by estrogen excess. Molecular Endocrinology 11 917-927.
32. Makino S, SmithMA & Gold PW 1995 Increased expression of corticotropinreleasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels. Endocrinology 136 3299-3309.
33. Malkoski SP & Dorin RI 1999 Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of thehuman corticotropin-releasing hormone gene. Molecular Endocrinology 13 1629-1644.
34. McGuire JS, Hollis VW & Tomkins GM 1960 Some characteristics of the microsomal steroid reductases (5α) of rat liver. Journal of Biological Chemistry 235 3112-3117.
35. McNeilly AD,MacFarlaneDP, O'Flaherty EN, LivingstoneDEW,MacKenzie SM, Mitic T, McConnell KM, Davies E, Reynolds RM, Thiesson HC et al. 2010 Bile acids modulate glucocorticoid metabolism and the hypothalamic- pituitary-adrenal axis in obstructive jaundice. Journal of Hepatology 52 705-711.
36. Phillipov G, Palermo M & Shackleton CHL 1996 Apparent cortisone reductase deficiency: a unique form of hypercortisolism. Journal of Clinical Endocrinology and Metabolism 81 3855-3860.
37. Reichardt HM, Umland T, Bauer A, Kretz O & Schutz G 2000 Mice with an increased glucocorticoid receptor gene dosage show enhanced resistance to stress and endotoxic shock. Molecular and Cellular Biology 20 9009-9017.
38. Rittmaster RS, Antonian L, New MI & Stoner E 1994 Effect of finasteride on adrenal steroidogenesis in men. Journal of Andrology 15 298-301.
39. Russell JA & Brunton PJ 2006 Neuroactive steroids attenuate oxytocin stress responses in late pregnancy. Neuroscience 138 879-889.
40. Stewart PM, Corrie JET, Shackleton CHL & Edwards CRW 1988 Syndrome of apparent mineralocorticoid excess: a defect in the cortisol-cortisone shuttle. Journal of Clinical Investigation 82 340-349.
41. Stewart PM, Shackleton CHL, Beastall GH & Edwards CRW 1990 5α-reductase activity in polycystic ovarian syndrome. Lancet 335 431-433.
42. Taylor NF, Bartlett WA, Dawson DJ & Enoch BA 1984 Cortisone reductase deficiency: evidence for a new inborn error in metabolism of adrenal steroids. Journal of Endocrinology 102(Suppl) 90.
43. Thigpen AE, Silver RI,Guileyardo JM, CaseyML, McConnell JD & Russell DW 1993 Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression. Journal of Clinical Investigation 92 903-910.
44. Tobyn VA & Canny BJ 1998 The regulation of gonadotropin-releasing hormone-induced calcium signals in male rat gonadotrophs by testosterone is mediated by dihydrotestosterone. Endocrinology 139 1038-1045.
45. Tsai MH, Peng YS, Cheng YC, Liu NJ, Ho YP, Fang JT, Lien JM, Yang C, Chen P-C & Wu C-S 2006 Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology 43 673-681.
46. Tsilchorozidou T, Honour JW & Conway GS 2003 Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5α-reduction but not the elevated adrenal steroid production rates. Journal of Clinical Endocrinology and Metabolism 88 5907-5913.
47. Upreti R, Hughes KA, Livingstone DEW, Gray CD, Minns FC, MacFarlane DP, Marshall I, Stewart LH, Walker BR & Andrew R 2014 5α-Reductase type 1 modulates insulin sensitivity in men. Journal of Clinical Endocrinology and Metabolism [in press].
48. Uygur MC, Arik AI, Altug U & Erol D 1998 Effects of the 5α-reductase inhibitor finasteride on serum levels of gonadal, adrenal, and hypophyseal hormones and its clinical significance: a prospective clinical study. Steroids 63 208-213.